UK tribunal denies excessive-pricing appeals
The UK’s Competition Appeal Tribunal has denied separate requests from the Competition and Markets Authority, Pfizer and Flynn Pharma to appeal against aspects of its phenytoin excessive-pricing decision last month, and ordered an immediate remittal of the case to the authority.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10